872
F. A. Davis, T. Ramachandar / Tetrahedron Letters 49 (2008) 870–872
several drug candidates,11 and the structural diversity of
available sulfinimine-derived a-amino 1,3-dithianes make
this protocol well suited for enantiomer and analog
synthesis.10
7. For earlier asymmetric synthesis of THFG see: (a) Williams, R. M.;
Sinclair, P. J.; Zhai, D.; Chen, D. J. Am. Chem. Soc. 1988, 110, 1547–
1557; (b) Horikawa, M.; Busch-Petersen, J.; Corey, E. J. Tetrahedron
Lett. 1999, 40, 3843–3846; (c) Kazamaier, U.; Pahler, S.; Endermann,
R.; Habich, D.; Kroll, H.-P.; Riedl, B. Bioorg. Med. Chem. 2002, 10,
3905–3913; (d) Jirgensons, A.; Marinozzi, M.; Pellicciari, R. Tetra-
hedron 2005, 61, 373–377.
Acknowledgment
8. For earlier asymmetric syntheses of (+)-4 see: (a) Bhaskar, G.; Rao,
B. V. Tetrahedron Lett. 2003, 44, 915–917; (b) Huang, P.-Q.; Liu,
L.-X.; Wei, B.-G.; Ruan, Y.-P. Org. Lett. 2003, 5, 1927–1929; (c)
Kandula, S. R. V.; Kumar, P. Tetrahedron: Asymmetry 2005, 16,
3579–3583; (d) Yoon, Y.-J.; Joo, J.-E.; Lee, K.-Y.; Kim, Y.-H.; Oh,
C.-Y.; Ham, W.-H. Tetrahedron Lett. 2005, 46, 739–741; (e) Oshitari,
T.; Mandai, T. Synlett 2006, 3395–3398; (f) Cherian, S. K.; Kumar, P.
Tetrahedron: Asymmetry 2007, 18, 982–987.
This work was supported by grants from the National
Institute of General Medicinal Sciences (GM57878 and
GM51982).
References and notes
9. For related 2,3-disubstituted piperidines see: (a) Liu, L.-X.; Ruan,
Y.-P.; Guo, Z.-Q.; Huang, P.-Q. J. Org. Chem. 2004, 69, 6001–6009;
(b) Lemire, A.; Grenon, M.; Pourashraf, M.; Charette, A. B. Org.
Lett. 2004, 6, 3517–3520; (c) Takahashi, K.; Nakano, H.; Fujita, R.
Tetrahedron Lett. 2005, 46, 8927–8930.
10. (a) Baker, R.; Harrison, T.; Swain, C. J.; William, B. J. EP 0
528,495A1, 1993; (b) Harrison, T.; Williams, B. J.; Swain, C. J.; Ball,
R. G. Bioorg. Med. Chem. Lett. 1994, 4, 2545–2550.
1. For reviews on the synthesis of chiral a-amino aldehydes and ketones
see: (a) Jurczak, J.; Golebiowski, A. Chem. Rev. 1989, 89, 149–164; (b)
Fisher, L. E.; Muchowski, J. M. Org. Prep. Proced. Int. 1990, 22, 399–
484; (c) Reetz, M. T. Chem. Rev. 1999, 99, 1121–1162; (d) Gryko, D.;
Chalko, J.; Jurczak, J. Chirality 2003, 15, 514–541.
2. Davis, F. A.; Ramachandar, T.; Liu, H. Org. Lett. 2004, 6, 3393–
3395.
3. Davis, F. A.; Ramachandar, T.; Chai, J.; Skucas, E. Tetrahedron Lett.
2006, 47, 2743–2746.
4. For recent reviews on the chemistry of sulfinimines see: (a) Zhou, P.;
Chen, B.-C.; Davis, F. A. Tetrahedron 2004, 60, 8003–8030; (b)
Senanayake, C. H.; Krishnamurthy, D.; Lu, Z.-H.; Han, Z.; Gallou, I.
Aldrichim. Acta 2005, 38, 93–104; (c) Morton, D.; Stockman, R. A.
Tetrahedron 2006, 62, 8869–8905; (d) Davis, F. A. J. Org. Chem. 2006,
71, 8993–9003.
5. Wei, W.-G.; Yao, Z.-J. Tetrahedron 2003, 59, 6621–6625.
6. Davis, F. A.; Zhang, Y.; Andemichael, Y.; Fang, T.; Fanelli, D. L.;
Zhang, H. J. Org. Chem. 1999, 64, 1403–1406.
11. For leading references see: Davis, F. A.; Zhang, Y.; Li, D.
Tetrahedron Lett. 2007, 48, 7838–7840.
20
12. Selected data: (+)-8, mp 109–110 °C; ½aꢁD 30.8 (c 0.4, CHCl3); (ꢀ)-
20
20
10, mp 93–95 °C; ½aꢁD ꢀ161.4 (c 0.42, CHCl3); (+)-11, ½aꢁD +26.5 (c
20
20
0.7, CHCl3); (+)-12, ½aꢁD 44.7 (c 1.3, CHCl3); (+)-13, ½aꢁD 16.8
20
20
(c 0.81, CHCl3); (+)-14, ½aꢁD +11.5 (c 0.68, CHCl3); (+)-5, ½aꢁD
20
+34.4 (c 1.1, CHCl3); (+)-16, ½aꢁD +27.1 (c 0.72, CHCl3); (+)-17,
20
20
mp 152–153 °C; ½aꢁD +35.1 (c 0.4, CHCl3); (+)-18, ½aꢁD +59.2
20
20
(c 0.32, CHCl3); (+)-19, ½aꢁD +76.31 (c 0.38, CHCl3); (+)-20, ½aꢁD
25
+58.6 (c 0.53, CHCl3); (+)-4, ½aꢁD +36.12 (c, 0.64, CHCl3).